SPI
18.219,49
PKT
+34,44
PKT
+0,19
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.08.12 | Nestlé outperform | Cheuvreux SA | |
| 09.08.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 09.08.12 | Swisscom neutral | Nomura | |
| 09.08.12 | Swisscom hold | Deutsche Bank AG | |
| 09.08.12 | Forbo International buy | UBS AG | |
| 09.08.12 | Zurich Insurance buy | ING | |
| 09.08.12 | Nestlé hold | Vontobel Research | |
| 09.08.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 09.08.12 | Inficon buy | Vontobel Research | |
| 09.08.12 | Adecco SA buy | Vontobel Research | |
| 09.08.12 | Bucher Industries hold | Vontobel Research | |
| 09.08.12 | Swiss Re buy | Vontobel Research | |
| 08.08.12 | Arbonia neutral | UBS AG | |
| 08.08.12 | OC Oerlikon buy | UBS AG | |
| 08.08.12 | Emmi neutral | UBS AG | |
| 08.08.12 | Swisscom neutral | Sarasin Research | |
| 08.08.12 | ams-OSRAM buy | UBS AG | |
| 08.08.12 | Adecco SA buy | ING | |
| 08.08.12 | Peach Property Group buy | SRC Research GmbH | |
| 08.08.12 | Arbonia hold | Vontobel Research | |
| 08.08.12 | Swisscom hold | Vontobel Research | |
| 08.08.12 | Clariant sell | Société Générale Group S.A. (SG) | |
| 08.08.12 | Rieter buy | Vontobel Research | |
| 07.08.12 | Arbonia neutral | Sarasin Research | |
| 07.08.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 07.08.12 | Givaudan neutral | Credit Suisse Group | |
| 07.08.12 | Givaudan underperform | Cheuvreux SA | |
| 07.08.12 | Richemont neutral | J.P. Morgan Cazenove | |
| 07.08.12 | LEM hold | Vontobel Research | |
| 07.08.12 | Arbonia hold | Vontobel Research | |
| 07.08.12 | OC Oerlikon buy | Vontobel Research | |
| 07.08.12 | Komax hold | Vontobel Research | |
| 07.08.12 | BELIMO hold | Vontobel Research | |
| 06.08.12 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 06.08.12 | Givaudan sell | Citigroup Corp. | |
| 06.08.12 | Givaudan reduce | Nomura | |
| 06.08.12 | VP Bank neutral | Sarasin Research | |
| 06.08.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 06.08.12 | Givaudan equal-weight | Morgan Stanley | |
| 06.08.12 | EFG International neutral | Sarasin Research |